ClinicalTrials.gov
public full text
Public Domain
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
breast-cancermetastatic-breast-cancertnbc-triple-negative-breast-cancertriple-negative-breast-cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Related documents
- Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC#852648
- Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma#230410
- Clinical Study on Triple Negative Breast Cancer With Chinese Medicine#1044302
- Chronic Liver Disease and Radiation-induced Second Primary Liver Malignancy#904956
- Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma#444862
Record · ID 353297 · SHA-256 66ba04e716eacfbd
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive